NIH-funded research NIH-funded research

Investigating how lung microbiota affects susceptibility to respiratory infections

Official title: Lung Dysbiosis and Increased Host Susceptibility to Respiratory Pathogens

Funded at VA Medical Center · NIH-10911082 · Data updated 2026-11-12

This study is looking at how the tiny germs in your lungs might affect your chances of getting sick from respiratory infections, especially for Veterans, and it hopes to find new ways to help improve lung health by understanding how these germs work with your immune system.

More Dysbiosis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Medical Center
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2022
Project endJuly 31, 2027
Funding year2024
NIH project number5IK2BX005309-03
Project IDNIH-10911082 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Veterans suffering from chronic lung diseases such as COPD or those experiencing recurrent respiratory infections.

Less likely to help

Patients without chronic lung conditions or those not exposed to respiratory pathogens may not benefit from this research.

What this research studies

This research explores the relationship between lung microbiota and the body's susceptibility to respiratory pathogens, particularly in Veterans. It utilizes advanced sequencing techniques to identify microbial communities in the lower airways and examines how dysbiosis, or imbalance in these communities, can lead to increased inflammation and immune response issues. The study aims to understand how specific microbial metabolites, like short-chain fatty acids, influence immune function and pathogen resistance through pre-clinical models. By focusing on chronic lung conditions, the research seeks to uncover potential new therapeutic strategies for improving lung health.

Why it matters

Potential benefit: If successful, this research could lead to more targeted and effective treatments for respiratory infections, reducing reliance on broad-spectrum antibiotics.

How similar studies have gone: Previous research has shown promising results in understanding the role of lung microbiota in respiratory health, indicating that this approach has potential for significant findings.

Where this research is happening

  • VA Medical Center
    New York, United States
    Active

Researchers

  • Principal investigator: Wu, Benjamin G — VA Medical Center
  • Study coordinator: Wu, Benjamin G

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.